Skip to main content
SpringerLink
Log in

Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington’s, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. De Marco N, Buono M, Troise F, Diez-Roux G (2006) Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J Biol Chem 281:16147–16156

    Article  PubMed  Google Scholar 

  2. Hortobagyi T, Troakes C, Nishimura AL et al (2011) Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders. Acta Neuropathol 121:519–527

    Article  PubMed  CAS  Google Scholar 

  3. Ito H, Fujita K, Nakamura M et al (2011) Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease. Acta Neuropathol 121:555–557

    Article  PubMed  Google Scholar 

  4. Maruyama H, Morino H, Ito H et al (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465:223–226

    Article  PubMed  CAS  Google Scholar 

  5. Okita S, Morigaki R, Koizumi H, Kaji R, Nagahiro S, Goto S (2012) Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington’s disease. Neuroscience 202:363–370

    Article  PubMed  CAS  Google Scholar 

  6. Osawa T, Mizuno Y, Fujita Y, Takatama M, Nakazato Y, Okamoto K (2011) Optineurin in neurodegenerative diseases. Neuropathology 31:569–574

    Article  PubMed  Google Scholar 

  7. Schwab C, Yu S, McGeer EG, McGeer PL (2012) Optineurin in Huntington’s disease intranuclear inclusions. Neurosci Lett 506:149–154

    Article  PubMed  CAS  Google Scholar 

  8. Schwab C, Yu S, McGeer PL (2012) Optineurin is colocalized with ubiquitin in Marinesco bodies. Acta Neuropathol 123:289–292

    Article  PubMed  Google Scholar 

  9. Swarup G, Nagabhushana A (2010) Optineurin, a multifunctional protein involved in glaucoma, amyotrophic lateral sclerosis and antiviral signalling. J Biosci 35:501–505

    Article  PubMed  Google Scholar 

  10. Takahashi T, Katada S, Onodera O (2010) Polyglutamine diseases: where does toxicity come from? What is toxicity? Where are we going? J Mol Cell Biol 2:180–191

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, a Grant for Hirosaki University Institutional Research (K.W.), the Collaborative Research Project (2011–2209) of the Brain Research Institute, Niigata University (F.M.), Grants-in Aid from the Research Committee for Ataxic Disease, the Ministry of Health, Labour and Welfare, Japan (K.W.), and the Intramural Research Grant (21B-4) for Neurological and Psychiatric Disorders of NCNP (K.W.).

Conflict of interest

The authors report no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan

    Fumiaki Mori, Kunikazu Tanji & Koichi Wakabayashi

  2. Department of Pathology, Brain Research Institute, University of Niigata, Niigata, Japan

    Yasuko Toyoshima & Hitoshi Takahashi

  3. Department of Neuropathology, Aichi Medical University, Nagakute-cho, Aichi, Japan

    Mari Yoshida

  4. Department of Pathological Neuroscience, Center for Bioresource-based Researches, Brain Research Institute, University of Niigata, Niigata, Japan

    Akiyoshi Kakita

Authors
  1. Fumiaki Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kunikazu Tanji
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuko Toyoshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mari Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akiyoshi Kakita
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hitoshi Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Koichi Wakabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fumiaki Mori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mori, F., Tanji, K., Toyoshima, Y. et al. Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington’s, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease. Acta Neuropathol 123, 747–749 (2012). https://doi.org/10.1007/s00401-012-0956-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-012-0956-x

Keywords

Search

Navigation